Position in BMEA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,011,672
-$122,926 QoQ
Shares Held
2,048,757
0.0% QoQ
Ownership
2.83%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#4
of 61 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMEA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aisling Capital Management LP holds $451,349,309 across 13 Biotechnology names. BMEA ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
4,589,611 | $341,834,227 | |
| 2 | GLUE |
Monte Rosa Therapeutics, Inc.
|
1,555,664 | $37,647,068 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,316,806 | $28,785,379 | |
| 4 | BCAX |
Bicara Therapeutics Inc.
|
568,919 | $16,891,205 | |
| 5 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
1,018,018 | $7,757,297 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
77,031 | $4,236,705 | |
| 7 | URGN |
UroGen Pharma Ltd.
|
108,000 | $3,974,400 | |
| 8 | BMEA |
Biomea Fusion, Inc.
This page
|
2,048,757 | $3,011,672 |
All Filings in BMEA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,011,672 | 2,048,757 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,134,598 | 2,048,757 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,540,458 | 2,048,757 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,138,489 | 2,048,757 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,687,762 | 2,048,757 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,701,352 | 798,757 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,099,177 | 798,757 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,067,445 | 798,757 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,594,406 | 798,757 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $11,941,417 | 798,757 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $11,597,951 | 798,757 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $10,990,896 | 798,757 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,532,716 | 798,757 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,769,454 | 798,757 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $6,733,521 | 798,757 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,811,843 | 798,757 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $9,569,108 | 798,757 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,562,456 | 798,757 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,950,739 | 798,757 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $9,561,121 | 798,757 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,468,596 | 798,757 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||